Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia.
about
Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Long-Term Exposure to Imatinib ...... Chronic Myelogenous Leukemia.
@en
Long-Term Exposure to Imatinib ...... Chronic Myelogenous Leukemia.
@nl
type
label
Long-Term Exposure to Imatinib ...... Chronic Myelogenous Leukemia.
@en
Long-Term Exposure to Imatinib ...... Chronic Myelogenous Leukemia.
@nl
prefLabel
Long-Term Exposure to Imatinib ...... Chronic Myelogenous Leukemia.
@en
Long-Term Exposure to Imatinib ...... Chronic Myelogenous Leukemia.
@nl
P2093
P2860
P50
P356
P1476
Long-Term Exposure to Imatinib ...... f Chronic Myelogenous Leukemia
@en
P2093
Alexander Tepper
Anna Chorzalska
Diana O Treaba
Dmitry Terentyev
John Morgan
Karim Roder
Nagib Ahsan
Olin Liang
Patrycja M Dubielecka
Philip A Gruppuso
P2860
P304
P356
10.1089/SCD.2016.0262
P577
2017-02-27T00:00:00Z